Trial Profile
Examination of Bone Metabolism and Bone Mineral Density by Zoledronic Acid in Primary and Secondary Osteoporosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Alfacalcidol
- Indications Osteoporosis
- Focus Therapeutic Use
- 20 Sep 2021 Planned End Date changed from 8 Jun 2024 to 8 Jun 2025.
- 20 Sep 2021 Planned primary completion date changed from 8 Dec 2021 to 8 Dec 2022.
- 10 Aug 2020 Planned End Date changed from 8 Jun 2022 to 8 Jun 2024.